3Antithrombotie Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ ,2002,324:71-86.
4Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease : a statement for healthcare professionals from the American Heart Association. Circulation, 1999,100 : 1134-1146.
5American Diabetes Association. Prevention or delay of type 2 diabetes ( Position Statement ). Diabetes Care, 2004, 27 ( Suppl 1 ) :S47-S54.
6UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type2 diabetes. Lancet,1998, 352:854- 865.
7Pignone M, Earnshaw S, Tice JA, et al. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med,2006, 144:326-336.
2WHO. Women and tobacco. World Health Organization, Geneva,1992.22-23.
3The Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob Control, 2002, 11:252-270.
4Office on Smoking and Health, CDC. Selected cigarette smoking initiation a quitting behaviours among high school students -United States, 1997.MMWR,1998,47:229-233.
5Crump C, Packer L, Gfroerer J. Incidence of initiation of cigarette smoking - United States, 1965-1996. MMWR, 1998, 47: 837-840.
6Jha P,Novotny TE,Feachem R. The role of governments in global tobacco control. In: Abedian I,van der Merwe R,Wilkins N,et al,eds. The economics of tobacco control. Towards an Optimal Policy Mix. 1st ed. Applied Fiscal Research Center, University of Cape Town, 1998.41-43.
7WHO. Tobacco or health: a global status report. Geneva: World Health Organization, 1997.
8The American cancer society Inc. Tobacco control country profiles,2000.
7KARAKITSOS P, POULIAKIS A, KORDALIS G, et al. Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract [ J]. Anal Quant Cytol Histol,2005, 27( 1 ) :35-42.
8FRIEDEWALD W T, LEVY R I, FREDRICKSON D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge[ J]. Clin Chem, 1972, 18: 499-502.
9SONKE G S, HESKES T, VERBEEK A L, et al. Prediction of bladder outlet obstruction in men with lower urinary tract symptoms using artificial neural networks[ J]. J Urol, 2000, 163 (1): 300- 305.
10WADIDIE B S, BADAWI A M, ABDELWAHED M, et al. Application of artificial neural network in prediction of bladder outlet obstruction: a model based on objective, noninvasive parameters [J]. Urology, 2006, 68(6) :1211-1214.
